0001209191-22-055548.txt : 20221103
0001209191-22-055548.hdr.sgml : 20221103
20221103170922
ACCESSION NUMBER: 0001209191-22-055548
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221102
FILED AS OF DATE: 20221103
DATE AS OF CHANGE: 20221103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Byam Rebecca
CENTRAL INDEX KEY: 0001866256
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40591
FILM NUMBER: 221359067
MAIL ADDRESS:
STREET 1: C/O HCW BIOLOGICS, INC.
STREET 2: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: HCW Biologics Inc.
CENTRAL INDEX KEY: 0001828673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 825024477
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
BUSINESS PHONE: 954-842-2024
MAIL ADDRESS:
STREET 1: 2929 N COMMERCE PKWY
CITY: MIRAMAR
STATE: FL
ZIP: 33025
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-11-02
0
0001828673
HCW Biologics Inc.
HCWB
0001866256
Byam Rebecca
C/O HCW BIOLOGICS INC
2929 N. COMMERCE PARKWAY
MIRAMAR
FL
33025
0
1
0
0
Chief Financial Officer
Common Stock
2022-11-02
4
M
0
33750
0.14
A
361702
D
Stock Option Grant (Right to Buy)
0.14
2022-11-02
4
M
0
33750
0.00
D
2029-12-19
Common Stock
33750
47249
D
These option shares were part of a stock option grant covering 135,000 shares of common stock. 20% of the total shares subject to the stock option grant vested on October 10, 2020; 20% of the total shares subject to the stock option grant vested on October 10, 2021; 25% of the total shares subject to the stock option grant will vest on October 10, 2022; and 35% of the total shares subject to the stock option grant will vest on October 10, 2023, subject to her continuous service through the applicable vesting date. The option is subject to additional vesting acceleration pursuant to her Employment Agreement.
/s/ Rebecca A. Byam
2022-11-03